Introduction
It is known that the joint cartilage of individuals with OA is highly metabolically active, engaging in a process of remodeling and repair of damaged tissue [1] . Cartilage degrading enzymes have been classified as matrix metalloproteinases (MMPs) which degrade collagen and other proteins and aggrecanases which degrade aggrecan. Continued activity of these enzymes leads the progression of osteoarthritis (OA). These enzymes cleave the ag-grecan core protein at aggrecanase-specific cleavage sites between glutamate and a hydrophobic amino acid residue [2] . For this reason, aggrecan catabolism has been studied for several decades as a part of metabolic routes which are very important in normal cartilage function and cartilage pathologies. The enzymes involved in aggrecan degradation in both normal and abnormal conditions of cartilage are aggrecanases, subclasses of ADAMTS (A disintegrin and metalloproteinase with thrombospondin motifs). They can show multiple isoforms due to alternative splicing and they degrade extracellular matrix components. They are translated initially as inactive pre-proenzymes, whose structure includes a signal peptide followed by a pro-domain, a catalytic domain, a disintegrinlike domain, a central thrombospondin type I-like repeat, a cysteine-rich domain, a spacer domain, a spacer region, and a variable number of C-terminal TS repeats [3] . Although the members of ADAMTS family have been implicated in a wide range of diseases, the most prominent evidences were obtained in arthritis, especially in OA [4] .
The American College of Rheumatology has published recommendations for the medical management of OA [5] which include control of pain and improvement in function and health-related quality of life, with avoidance of toxic effects of therapy. Implied in these goals is that non-pharmacological modalities should be considered as first interventions or together with first-line drug therapies [6] .
Caffeic acid phenethyl ester (CAPE) (Figure 1 ), an active component of propolis, has extensively been used as a protective agent in several disease models of chemotherapy and radiotherapy-induced toxicities [7] [8] [9] [10] [11] [12] [13] [14] [15] . It is a specific and potent NF-κB inhibitor in vitro at concentration of 10µM and in a dose-and time-dependent manner [16] . Many studies have pointed out the anti-inflammatory properties of bee products and it was attributed to the presence of flavonoids that inhibit the development of inflammation provoked by a variety of agents [17] . Using headspace solid-phase microextraction followed by diethyl ether and methanol extractions, it was possible to isolate about 185 organic compounds from crude royal jelly (RJ) [18] . 10-hydroxy-2-decenoic acid (10H2DA) (Figure 1 ) is known to be one of the most important ingredient of RJ ever [19] . The other compound, curcumin, is the main curcuminoid component of curcuma longa (Figure 1 ). It appears to have anti-inflammatory properties by using COX-2, prostaglandins, and leukotrienes pathways [20] . Although some preliminary clinical researches suggest beneficial effects on symptoms of rheumatoid arthritis (RA), there is no data for the effectiveness of curcumin in OA [21] .
Because the main characteristic that occurs in the disease is the uncontrolled production of matrix degrading enzymes, the main purpose of this study was to investigate the repressive effect of CAPE, RJ and curcumin on the NF-κB pathway which is a main responsible element in OA pathogenesis and find a valuable alternative remedy for the damage of joint cartilage. The second objective was to develop an accurate, cost-effective, and proven sophisticated method for studying several genes of the aggrecanases family, ADAMTS-1, -5, and -9.
Methods Reagents, chemicals and instruments IL-1α was purchased from R&D Systems, Minneapolis, ML. CAPE, curcumin, and BAY 11-7085 was purchased from Sigma Chemical Corporation, St. Louis, MO. Royal jelly lyophilized powder was purchased from Afye, Deva Destek Hiz., Ankara. The instruments used were Techne TC-3000X PCR thermocycler (normal PCR) (USA), Techne TC-5000 PCR thermocycler (Gradient PCR) (USA), Schimadzu UV-Pharmaspec 1700 spectrophotometer (Japan) and Schimadzu Biotech Biospec-nano spectrophotometer (Japan).
Cell line and culture OUMS-27 chondrosarcoma cells were a kind gift from Dr. T. Kunisada (Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan) [22] . The cells were viewed using a Leica DM IL LED DFC 295 inverted microscope (Germany) and images were digitally captured using a built-in camera (Figure 2 ). There were six experiment condition for cultured OUMS-27 cells; control, IL-1α, CAPE, RJ, curcumin, and BAY groups each containing: 2 mL medium, 2 mL medium +2µL IL-1α, 2 mL medium + 2µL IL-1α and 2µL CAPE, 2 mL medium + 2µL IL-1α and 10 µL RJ", 2 mL medium + 2µL IL-1α and 2µL curcumin, and 2 mL medium + 2µL IL-1α and 2µL BAY, respectively (three wells for each condition). The cells were cultured in Dulbecco' s modified Eagle' s medium (DMEM) containing 10% fetal bovine serum (FBS), penicillin/streptomycin, glutamine, and plasmocin at 37°C in a humidified atmosphere of 5% CO2 in air. The cells were subcultured at split ratios of 1:2 to 1:4 using trypsin plus EDTA every 7-10 days. The medium was changed every 2-3 days. For the experiments, 1-1.5x10 5 cells were plated in 30-mm dishes for 24 hours and then exposed to the different cytokines and inhibitors at the concentrations and times indicated. Cytokine stimulation NF-κB inhibitor assay All cells were incubated in 2 ml of medium containing 10% FBS. After 72 hours, the cells were then exposed to 10 ng/ mL human recombinant IL-1α (R&D Systems, Minneapolis, ML) in phosphate buffered saline (PBS) or PBS containing 0.1% bovine serum albumin as a control for 6 hours. For the effects of inhibitors, cells were cultured on 30-mm wells for 24 hours before being stimulated. OUMS-27 cells were pretreated with CAPE (10µmol/L), RJ (12.5 µg/mL), curcumin (10µmol/L), BAY 11-7085 (10µmol/L), or DMSO alone (as a vehicle control) for 60 minutes and subsequently incubated with IL-1α (10 ng/mL).
mRNA preparation and quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR)
We stimulated OUMS-27 cells with recombinant human IL-1α and then the cells were washed out once with PBS and total RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA) reagent and adding chloroform according to manufacturer' s instruction. 1x10 5 -1.5x10 5 cells were used per petri dish. The aqueous phase was recovered after centrifugation at 12,000xg for 15 min. A known amount of RNA (1 µg) of total RNA was reverse transcribed to complementary DNA (cDNA) with random primers according to the manufacturer' s protocol (Fermentas, Thermo Sci, USA). The reaction mixture is shown in Table 1 . Primers for PCR were designed to amplify 90-700 bp fragments for each gene (β-Actin, AD-AMTS-1, -5, and -9) ( Table 2) .
The cDNAs were subjected to real-time PCR amplification using specific primer sets for ADAMTS-1, -5, and -9 and β-Actin as previously described [23] . A quantitative real-time
Order
The mixture Amount RT-PCR analysis was performed using Qiagen Rotor-Gene Q RT-PCR thermal cycler system (Germany). The PCR mixture consisted of 19 SYBR Green PCR Master Mix which includes DNA polymerase, SYBR Green I Dye, dNTPs including dUTP, PCR buffer, 10 pmol forward and reverse primers (Table 2), and cDNA of samples in a total volume of 20 µL. The amplification of a housekeeping gene, β-Actin, was used for normalizing the efficiency of cDNA synthesis and the amount of RNA applied. To validate the specificity of amplification of ADAMTS-1, -5, and -9 and β-Actin, we analyzed each PCR product by agarose gel electrophoresis after real-time detection ( Figure 3 ). All the experiments were performed at least twice in triplicate wells. Negative controls were performed with samples in which the RNA templates were replaced by nuclease-free water in the reactions. Subsequently, the threshold cycle (Ct), i.e., the number of cycles at which the amount of the amplified gene of interest reached a fixed threshold, was determined. We performed gradient PCR to optimize the reaction conditions following PCR steps. The master mix solution for gradient PCR is seen in Table 3 . PCR was performed with initial denaturation at 95 ºC for 5 min, followed by amplification for 36 cycles, each cycle consisting of denaturation at 95 ºC for 30 sec, annealing at 58 ºC for 30 sec, and polymerization at 72ºC for 1 min, and the last stage, polymerization at 72 ºC for 5 min (Table 4 ).
Statistical analyses
The data for ADAMTS genes were represented as graphics in the results section. The bars and error bars represent mean and standard deviation, respectively. Statistical Package for Social Studies (SPSS) version 16.0 was used for all statistical tests. Nonparametric tests were applied because of the limited number of repeated experiments. The relationships between the variables were tested by Mann-Whitney U test. p=0.05 and<0.05 was accepted as significant for all tests.
Results We examined whether the expression level of ADAMTS mRNA was altered by IL-1α stimulation in OUMS-27 cells. For this purpose, we amplified the cDNA from unstimulated OUMS-27 cells by using ADAMTS-1, -5, and -9 primers. The PCR products were separated by electrophoresis on an agarose gel (3%), and specific bands corresponding to each gene product (ADAMTS-1 72 bp, ADAMTS-5 182 bp, AD-AMTS-9 67 bp, and β-Actin 204 bp) were observed in all instances ( Figure 3 ).
We characterized expression of ADAMTS-1, -5, and -9 mRNA upon induction with IL-1α of OUMS-27 chondrosarcoma cells. The cells were stimulated by 10 ng/mL for 6 hours and compared with unstimulated controls (n=3 independent experiments). The genes for enzyme that have aggrecanase activity were found to be induced upon IL-1α application. The expressions of these ADAMTS genes were increased in various rates. In terms of ADAMTS/β-ACTIN ratio, ADAMTS-1 gene expression was increased by two-fold after IL-1α induction. CAPE and curcumin led to a decrease in ADAMTS-1/β-ACTIN ratio but it was not statistically significant. BAY 11-7085 was not effective on ADAMTS-1/β-ACTIN ratio (Figure 4) . ADAMTS-5 gene expression was tested by three independent experiments and found to be increased by 1.6, 1.3, and 2.7 times, respectively follow-ing IL-1α induction ( Figure 5 ). In the first experiment, curcumin was found to decrease the ADAMTS-5/β-ACTIN ratio significantly (p=0.05). In the second experiment, CAPE and RJ were found to be effective on the ADAMTS-5/β-ACTIN ratio (p=0.025 and p=0.05, respectively). Although curcumin was still effective on that ratio, the difference was not significant compared to the IL-1α cell group. In the third experiment, CAPE, RJ, curcumin, and BAY all decreased the ADAMTS-5/β-ACTIN ratio compared to the IL-1α group but results were not statistically significant.
Similarly, ADAMTS-9 gene expression was found to be elevated by 2.5, 2.9 (p=0.024), and 4.2 times, respectively (Figure 6 ). The used compounds that have nuclear NF-κB inhibition potential prevented the elevation of gene expression in different ratios in especially in the first and third experiments but they were not statistically significant.
The most successful inhibitor compound for AD-AMTS-1 and -5 was curcumin, followed by the other inhibitors, CAPE, RJ, and BAY 11-7085. However, these compounds did not inhibit the gene expression of ADAMTS-9 compared to the other genes. The most successful inhibitor molecule for ADAMTS-9 was BAY 11-7085 followed by curcumin and CAPE.
Discussion
In this work, we have addressed the importance of AD-AMTS aggrecanases induced by cytokine IL-1α in OUMS-27 cell culture. We clearly demonstrated that ADAMTS genes were differentially regulated and that ADAMTS-5 was the most highly induced of the aggrecanase family of genes in IL-1α-stimulated chondrosarcoma cells. As stated before, OUMS-27 cells were isolated from a patient with chondrosarcoma (cancer cell) but they maintain the chondrocytic phenotype and they express cartilage specific proteoglycan, i.e. aggrecan [23] .
The reason why we studied only 3 genes out of 19 AD-AMTS genes is because the products of these genes are named aggrecanases and they show protease activity and they have an ability to digest the aggrecan protein. The reason for insignificant results from the experiments is that we had a limited number of repeats for cell culture and consequently limited number for the results obtained (2 or 3 repeats). This is the major limitation of our study. One of the original aspects of our study is that we used IL-1α to induce the cells for AD-AMTS expression in while most previous studies used IL-1β for that purpose [1, 24, 25] . When our findings are compared to the other, they suggest that IL-1α leads to an increase AD-AMTS gene expression as effectively as IL-1β.
In OA, persistent stress on joint tissues leads to inflammation at the plaque spot. On one hand, mechanical stress leads to increased production of cytokines and growth factors that induce progression and/or initiation of OA [24] . On the other hand, during OA, the activity of ADAMTS enzymes that we investigated in the present study are increased in articular chondrocytes, which changes the physiological balance between matrix synthesis and degradation and results in an enhanced aggrecan proteolysis [26, 27] . While cyclooxygenase-2 and inducible nitric oxide synthases are responsible for increased production of prostaglandins and leukotrienes, TNF-α and NF-κB are excessively active in OA and RA.
Current estimates of herbal medicinal products use in the United States, based on the 2002-2007 National Health Interview Survey data, range from 34% to 76%, depending on the therapies included in the definition of herbal medicinal products and population studied [28] . Forty-seven percent of older adults with OA use complementary medicine for their symptomatic therapies [29] . The mechanism of action of the herbal medicinal products is broader than that of the nonsteroidal anti-inflammatory drugs and/or analgesics in current use for OA. The exact mechanism of action is not wellknown but there are some evidences that all plant materials act via several pathways including cyclooxygenase, lypooxygenase, inhibition of cytokine release, inhibition of elastase or hyaluronidase, as well as antioxidant activity [30] . CAPE is an effective in vitro inhibitor of NF-κB and relevant cytokines [31] . Elmalı et al investigated the in vivo effects of CAPE, as a specific inhibitor of NF-κB, following intra-articular injection on the course of disease progression in an experimental OA model in rabbits [32] . Treatment of experimental OA with intra-articular injection of 150 µg/kg of CAPE in 0.5% ethanol daily for 2 weeks reduced cartilage pathology in histological specimens although the specific responsible mechanism is not well known. To better investigate the molecular mechanism of propolis and its active product CAPE on cartilage protection, researchers treated IL-1β stimulated cultures of human cartilaginous tissues and chondrocytes with CAPE at concentrations present in the propolis (17.5-35x10-6 M) [33] . They demonstrated that CAPE is able to reduce NO production and glucosaminoglycans (GAGs) release into the medium of human cartilaginous tissue cultures, and to prevent the inhibition of GAGs synthesis in chondrocytes. On the other hand, CAPE was found to have the capacity to inhibit 5-LO and LTs biosynthesis in human polymorphonuclear leukocytes (PMNL) and whole blood. CAPE inhibited 5-LO activities more effectively than zileuton for the inhibition of LT biosynthesis in PMNL but the compounds were found to be equipotent in whole blood. Inhibition of LT biosynthesis by CAPE was due to the inhibition of 5-LO and of AA release. As a result, researchers concluded that CAPE is a potent LT biosynthesis inhibitor that blocks 5-LO activity and AA release [34] . Matrix MPs play a pivotal role in tumor metastasis by cleavage of extracellular matrix as well as non-matrix substrates. Dose dependent decreases in MMP and TIMP (tissue inhibitor of metalloproteinase-2) mRNA levels were observed in CAPEtreated HT1080 human fibrosarcoma cells [35] .
The active compound of RJ, 10H2DA (Fig 1) , has been known to have collagen production-promoting activity [36] . 10H2DA was examined to see if it could inhibit TNF-α-induced production of MMPs through the activation of intracellular signaling pathways of mitogen-activated protein kinase (MAPK). It was reported that 10H2DA has dual inhibitory effects at the activity of MMP-1, MMP-3 and inhibition of p38 and JNK-AP-1 signaling pathways, on the other hand, it had no effect on extracellular signal-regulated kinase activity, NF-κB DNA-binding activity, and IκBα degradation [19] . The effects of RJ on the production of inflammatory cytokines from MPDL22 cells stimulated with lipopolysaccharide (LPS) was tested. RJ suppressed both LPS-induced IL-6 and CXC chemokine ligand 10 production from MPDL22 cells and the expression of CD54, the adhesion molecule involved in the accumulation of leukocytes in periodontal lesions, in MPDL22 cells [37] . The anti-inflammatory action of RJ at the cytokine level was examined. When supernatant containing RJ was added to a culture of mouse peritoneal macrophages stimulated by LPS/IFN-γ, it was found that RJ inhibited the production of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1 in a dose-dependent manner without having cytotoxic effects on macrophages [38] . From this, researchers suggested that RJ can be used as an effective dietary supplement for the improvement of quality of life in autoimmune diseases such as RA. RJ was administered to the mice that genetically exhibit many manifestations similar to human systemic lupus erythematosus (SLE) and a decrease in the serum level of IL-10, and in the autoantibodies against ssDNA, ds-DNA and erythrocytes was found as well as a reduction in the number of splenic autoreactive B cells [39] .
During inflammatory conditions, the functional influence of lymphocytes and the related cross-talk can be modulated by curcumin to achieve desired immune status against disease [40] . Although the results are encouraging for cell culture, there are some problems associated with the metabolism and bioavailability of curcumin for systemic usage. The bioavailability of naturally occurring curcumin is low because the absorption and metabolism of the molecule in the gastrointestinal system results in the rapid loss of its unique properties in vivo, so, when ingested orally, very little may actually reach the systemic circulation [41] . Curcumin is converted to its degradation products, curcumin glucuronides and curcumin sulfates as well as hexa-hydrocurcumin in the intestine and liver and these derivatives do not possess the same biological activity as the original compound [42] . Our findings about curcumin and the information given above are accordant to each other. We can say that curcumin inhibits the NF-κB pathway and eventually the expression of ADAMTS genes which damage cartilage tissue in the early stage.
Although mechanical, biochemical, and genetic factors seem to play a role, the etiology of OA is unclear. That is why a total curative intervention cannot be reached with current therapy tools. This study has investigated a number of promising alternatives for preventing and treating of OA and its symptoms. Preliminary evidence about ADAMTS/aggrecanase from the results suggests some of these agents may help arrest or reverse the disease process by inhibiting harmful effects of aggrecanase enzyme in the cartilage. Further studies dealing with other cells such as normal human chondrocytes are needed to demonstrate the detailed protective effects of these compounds.
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